| A PROSPECTIVE, OPEN-LABELED, RANDOMIZED, MULTICENTER PHASE II STUDY TO EVALUATE EFFICACY AND SAFETY OF ERLOTINIB VS NP CHEMOTHERAPY AS ADJUVANT THERAPY IN POST RADICAL OPERATION STAGE IIIA NSCLC PATIENTS WITH EGFR 19 OR 21 EXON MUTATION (EVAN, ML28280, NCT01683175) | |
| Yue, Dongsheng; Xu, Shidong; Li, Qiang; Liu, Junfeng; Li, Xiaofei; Ma, Haitao; Mao, Weimin; Yang, Yue; Wang, Qun; Chen, Chun | |
| 2013 | |
| 关键词 | NSCLC EGFR mutation post surgery erlotinib |
| 卷号 | 8 |
| 会议录 | JOURNAL OF THORACIC ONCOLOGY
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 1556-0864 |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4899989 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Yue, Dongsheng,Xu, Shidong,Li, Qiang,et al. A PROSPECTIVE, OPEN-LABELED, RANDOMIZED, MULTICENTER PHASE II STUDY TO EVALUATE EFFICACY AND SAFETY OF ERLOTINIB VS NP CHEMOTHERAPY AS ADJUVANT THERAPY IN POST RADICAL OPERATION STAGE IIIA NSCLC PATIENTS WITH EGFR 19 OR 21 EXON MUTATION (EVAN, ML28280, NCT01683175)[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论